Xcout Intel
Massive Bio
Massive Bio is a digital health company that combines AI-powered technology with physician expertise to analyze medical conditions and match patients with clinical trials. While it has offices in Istanbul, it is headquartered in New York City.
Subscribe to see Massive Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Massive Bio at a glance
Massive Bio is a healthtech company headquartered in United States. It has raised at least $21.6M across the 4 funding rounds on record, 3 of them with a disclosed amount. Its most recent funding round, Series A, raised $16.5M in December 2022. Xcout tracks 3 named people at Massive Bio, including Selin Kurnaz (Co-Founder, CEO).
Massive Bio leadership
- Selin KurnazCo-Founder, CEO
- Cagatay CulcuogluCo-Founder, CTO, COO & CLO
- Arturo Loaiza-BonillaCo-Founder and Chief Medical AI Officer
Massive Bio funding rounds
At least $21.6M raised across the 4 rounds on record (3 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $16.5M | 1 named | |
| — | Undisclosed | 1 named | |
| Series A | $2.6M | 2 named | |
| SEC Form D filing | $2.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Massive Bio news
Investors
Massive Bio competitors
A few of Massive Bio's closest competitors — see the full list of competitors and alternatives →
Ancora.ai is a Swiss digital-health company that uses artificial intelligence to help patients find clinical trials relevant to their conditions and circumstances. Its platform also supports healthcare professionals and clinical-trial sponsors in improving trial discovery and patient recruitment.
Beacon Biosignals is a healthtech company that uses EEG data, digital biomarkers, and machine learning to characterize brain activity and support neuroscience research and clinical drug development. It serves pharmaceutical and biotechnology companies, academic researchers, and clinical-trial teams working on neurological and psychiatric disorders.
Medable Inc. is a technology platform company providing AI-powered solutions for decentralized clinical trials. Based in Palo Alto, California, it supports the life sciences industry with software designed to streamline clinical research and patient engagement.
Beaconcure Inc. is a biotechnology and software company that develops AI-enabled clinical trial data solutions. The company was founded in 2016 and is based in Tel Aviv, Israel, with an office in Boston, United States.
Get Massive Bio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Massive Bio? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Massive Bio in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access